DYN Stock Discussion
Dyne Therapeutics, Inc. Description
Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. Dyne is developing a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
Industry: Biotechnology
Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Oligonucleotide Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Popular Now
Featured Articles